AXIOMPHARMACEUTICALS
AXIOMPHARMACEUTICALS
WhatsAppAccount
Research Use Only18+Not for Human ConsumptionReconstitution Materials Not Supplied
Peptide Database

Longevity & cellular

Epitalon (Epithalon)

Telomerase activation theoretically carries cancer risk, which is why Epitalon is contraindicated in active malignancy. However, 35+ years of research shows no increased cancer incidence in clinical trials. The key distinction: Epitalon activates telomerase in normal cells while cancer cells already have telomerase;…

Research use onlyGBP reference pricing where listedUK dispatch on catalogue items
View product →DatabaseRelated

Overview

Epitalon is a synthetic tetrapeptide developed by Russian scientist Vladimir Khavinson with 35+ years of research. It activates telomerase at extremely low concentrations to maintain telomere length, stimulates melatonin production, and modulates gene expression through epigenetic mechanisms.

Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms.

Activates telomerase at microgram doses to extend telomeres and cellular replicative lifespan.

Reverses aging markers and improves mitochondrial function at the cellular level.

Animal studies show 25-33% lifespan increases using 30-40mcg/kg doses.

Mechanism

Epitalon is a synthetic tetrapeptide developed by Russian scientist Vladimir Khavinson with 35+ years of research. It activates telomerase at extremely low concentrations to maintain telomere length, stimulates melatonin production, and modulates gene expression through epigenetic mechanisms.

Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms.

Activates telomerase at microgram doses to extend telomeres and cellular replicative lifespan.

Research areas

  • Epitalon is a synthetic tetrapeptide developed by Russian scientist Vladimir Khavinson with 35+ years of research. It activates telomerase at extremely low concentrations to maintain telomere length, stimulates melatonin production, and modulates gene expression through epigenetic mechanisms.
  • Activates telomerase at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates melatonin production from the pineal gland, and modulates gene expression through epigenetic mechanisms.
  • Activates telomerase at microgram doses to extend telomeres and cellular replicative lifespan.
  • Reverses aging markers and improves mitochondrial function at the cellular level.
  • Animal studies show 25-33% lifespan increases using 30-40mcg/kg doses.

Research notes

  • Generally well-tolerated with minimal side effects
  • Mild injection site reactions
  • Vivid dreams (melatonin-related)
  • Possible mild digestive upset (oral route)
  • Signs of allergic reaction

Protocol Variations

  • Multiple approaches exist - compare before choosing
  • Different sources recommend different protocols for this peptide. Review each approach and consider your goals, tolerance, and level before choosing.

High-Dose Community Protocol

  • Source: Biohacking Communities
  • "Higher doses for potentially stronger effects"
  • Widely circulated protocol recommending 5-10mg daily injections. This dosing lacks peer-reviewed human clinical data and may stem from translation errors of Russian research or extrapolation from other peptides. No published studies validate this dose range in humans.
  • 5-10mg daily (10-20x higher than research protocols)
  • No peer-reviewed human data at these doses

References

Questions

What's the correct Epitalon dosage—why do some sources recommend 5-10mg versus 0.5-1mg?

Peer-reviewed human clinical trials show efficacy at 0.5-1mg daily, while many community protocols recommend 5-10mg based on what appears to be translation errors from animal studies. Original research demonstrates microgram-level activation of telomerase, making lower doses research-supported. Higher doses lack human…

Does Epitalon really extend lifespan or is that just animal studies?

Animal studies show 25-33% lifespan extension with Epitalon, and a 6-8 year clinical trial of 266 elderly subjects found a 1.6-1.8 fold mortality reduction with Epithalamin. While impressive, human lifespan extension claims remain theoretical. Effects on cellular aging markers like telomere length are better…